Lipovation

Specializing in Lipid-based Nano/micro Particle Medicines

Health Tech & Life Sciences
Acquired by Revium Rx
Acquired Herzliya, Israel Founded 2021
Last updated 2026-08-23
Total raised
—
Stage
Acquired
Founded
2021
Headcount
9
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences

About

LipoVation was an Israeli development-stage company specializing in lipid-based nano/micro particle medicines. Its core technology was conceptualized by Prof. Yehezkel Barenholz, the inventor of Doxil, the first FDA-approved liposomal chemotherapy drug. The company became a wholly owned subsidiary of Revium Rx after its acquisition in February 2025.

Headcount over time

9 employees (2026-09) · 1 point
9 9 2026-09

Offices

Herzliya, Israel · HQ / main office

Q&A

What is Lipovation's primary focus?
Lipovation specializes in Lipid-based Nano/micro Particle Medicines.
Who conceptualized Lipovation's core technology?
Lipovation's core technology was conceptualized by Prof. Yehezkel Barenholz, the inventor of Doxil, an FDA-approved liposomal chemotherapy drug.
When was Lipovation founded?
Lipovation was founded in February 2021.
What is the current status of Lipovation?
Lipovation was acquired by Revium Rx in February 2025 and is currently inactive.
How many employees does Lipovation have?
Lipovation has 1-10 employees.
Where is Lipovation headquartered?
Lipovation is headquartered in Herzliya, Israel.
Who is the CEO of Lipovation?
The CEO of Lipovation is David Akunis.
Who is the CTO of Lipovation?
The CTO of Lipovation is Erez Koren.

Team · 3

Prof. Yehezkel Barenholz
Founder · Founder & Inventor
David Akunis
CEO
Erez Koren
CTO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2C
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitelipovation.com
LinkedInlinkedin.com/company/3738990

Identifiers & details

Legal nameLIPOVATION LTD
Founded2021-2
Employees (exact)9
Status reasonAcquired (Inactive) by Revium Rx on Feb 2025 - closed due to acquisition

Acquisitions & public offerings

Acquired by Revium Rx 2025-02

Radar intelligence

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516352408
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2021-02-28
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events0
Registered addressהמנופים 10 הרצליה